The leadership of the Society for Neuro-Oncology is monitoring developments related to the coronavirus disease (COVID-19) outbreak and its potential impact on our Society’s meetings. In the past week we have witnessed a rapidly changing situation and, consequently, we believe it is our responsibility to provide regular updates as circumstances warrant.
SNO has three conferences planned for later this year: Brain Metastases in Toronto, Canada (August, 2020), Brain Tumor Metabolism in Bethesda, Maryland, (October 2020) and our Annual Meeting in Austin, Texas (November, 2020).
At the present time, we are planning to hold these conferences as planned.
We have been in contact with all of our meeting venues and hotel partners to discuss contingency plans as well as appropriate measures we can take on-site, including increased availability of hand-sanitizing stations, increasing the frequency of cleaning and disinfecting public area surfaces, thorough disinfecting of bathrooms in public spaces, additional sanitizing of high-touch surfaces and door handles, and a campaign to promote touchless interactions with colleagues.
Ultimately, the health and safety of our registrants, partners and SNO staff remain our main concern. We will continue to follow guidance and recommended safety measures from the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO).
Updates and new information will be posted on the SNO website and circulated via Twitter @neuroonc.